Genmab — Juni 2019
-
Der kan kun være en konklusion på kapitaludvidelsen. Genmab har ikke kunnet finde en 50/50 partner som vil acceptere Jans vilkår til cd3/cd20 og DR5/DR5, og derfor skal beløbet bruges til at køre videre alene uden partner
-
jeg tror desværre, at du har ret
-
og det følger desværre linjen fra et par år siden, at der var kæmpe kø ved kassen for at lave teknik aftaler, denne gang blev vi overrendt af Big Pharma
-
Et godt bud GB.
-
Meddelelsen sagde vel at beløbet skal bruges til at investere i egen pipeline
-
Duo- og hexabody kræver store investeringer iflg eksperterne i chatten
-
-
-
-
Philippe Moreau on CASSIOPEIA https://www.oncologytube.com/video/daratumumab-phase-3-study-phase-3-randomized-study-of-daratumumab-bortezomib-thalidomide-dexamethasone-d-vtd-vs-vtd-in-transplant-eligible-ndmm/10006339 https://www.oncologytube.com/video/daratumumab-phase-3-study-could-be-a-pivotal-study-in-the-approval-of-daratumumab-in-the-united-states-europe-other-countries/10006340
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind